CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Meet the Editorial Board Member96
Meet the Regional Editor82
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation62
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus54
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease52
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis50
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment49
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease36
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation34
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives33
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis30
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 29
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis28
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health28
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia28
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease27
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound26
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review26
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota25
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature24
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches23
Insights into the Diagnosis, Treatment, and Management of Prion Diseases23
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies22
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders22
0.40648603439331